A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies.
Mosialou I, Ali AM, Labella R, Bisikirska B, Cuesta-Dominguez A, Vgenopoulou P, Reyes I, Rao SM, Wang A, Luo N, Galan-Diez M, Zhao J, Chernak BJ, Bewersdorf JP, Fukasawa K, Su J, Higa J, Adams RA, Corper AL, Pampou S, Woods CM, Fan X, Shah RP, Feldstein J, Liu N, Liang C, Heiblig M, Kornblau S, Garcia-Manero G, Berman E, Jurcic JG, Rabadan R, Raza A, Kousteni S.
Mosialou I, et al. Among authors: wang a.
Cancer Cell. 2025 Jun 9;43(6):1007-1024.e13. doi: 10.1016/j.ccell.2025.03.007. Epub 2025 Mar 27.
Cancer Cell. 2025.
PMID: 40154481
Free PMC article.